Auto-brewery syndrome (ABS) — also referred to as gut fermentation syndrome — is a rare and incompletely understood medical condition in which microorganisms residing in the gastrointestinal tract ferment dietary carbohydrates into ethanol. The result is endogenous alcohol production: the body generates alcohol internally, independent of any consumption, sometimes to levels detectable in blood or breath tests.
The condition has been described in the medical literature since the 1950s, but only a few hundred cases have been formally documented. It is almost certainly under-recognised. For those affected, the impact can be significant: presenting with apparent intoxication without having consumed alcohol is distressing, practically disruptive, and — in contexts such as driving or workplace incidents — potentially serious in its legal and social consequences.
What Causes Auto-Brewery Syndrome?
ABS results from an overgrowth of specific fermentative microorganisms in the gastrointestinal tract. Fungal species are most commonly implicated, particularly Saccharomyces cerevisiae (brewer's yeast), Candida albicans, and Candida glabrata. In some reported cases, bacterial organisms such as Klebsiella pneumoniae have been identified as the causative agent via a similar fermentation pathway.
For fermentation to occur at clinically relevant levels, an enabling environment in the gut appears necessary. Factors associated with ABS in published cases include prolonged antibiotic use (which can disrupt the gut microbiome and reduce bacterial competition with fungi), high-carbohydrate diets providing fermentation substrate, conditions affecting gut motility or anatomy (including short bowel syndrome and Crohn's disease), and impaired immune function. Not everyone exposed to these factors develops ABS, and why some individuals do while others do not is not yet fully understood.
Recognising the Symptoms
The symptoms of ABS can include episodes of apparent intoxication (disorientation, slurred speech, impaired coordination, mood changes), cognitive fog or difficulty concentrating, fatigue, bloating and gastrointestinal disturbance, and — when blood or breath alcohol testing is performed during an episode — measurable ethanol levels in the absence of consumption.
It is important to note that these symptoms are non-specific and have many other possible causes. Cognitive fog, fatigue, and gastrointestinal symptoms are common presentations across a very wide range of conditions. Intoxication-like states without alcohol consumption can result from metabolic disorders, neurological conditions, psychiatric presentations, and other causes. ABS should be considered within a thorough differential diagnostic process, not assumed from symptoms alone.
How Is Auto-Brewery Syndrome Investigated?
Investigation of suspected ABS is specialist-led and should be coordinated by a gastroenterologist, infectious disease specialist, or metabolic medicine clinician. The cornerstone of formal diagnosis in reported cases is a controlled provocation test: the individual consumes a standardised carbohydrate load under monitored fasting conditions (having confirmed no prior alcohol consumption), and serial blood alcohol levels are taken at intervals over several hours.
A rise in blood alcohol without exogenous consumption, during a properly controlled test, provides objective evidence of endogenous ethanol production. Stool culture, gut microbiome analysis, and in some cases intestinal biopsy may be used to identify the causative organism. Upper and lower gastrointestinal investigations may be performed to assess for structural or inflammatory conditions that may be contributing.
The investigation pathway is not yet standardised across health systems, and access to specialists with specific ABS experience varies. In the UK, those seeking investigation would typically receive a referral from their GP to gastroenterology as the entry point.
Management Approaches in Published Cases
No randomised controlled trials exist for ABS management — the evidence base consists entirely of case reports and small series. However, several approaches have been associated with symptom resolution or significant improvement in published cases:
Dietary modification is the most consistently reported intervention. Reducing dietary carbohydrate and sugar intake removes the fermentation substrate, and many cases describe substantial symptom reduction with a low-carbohydrate dietary approach maintained under dietetic supervision.
Antifungal therapy (most commonly fluconazole or other azole antifungals) has been used where a fungal organism has been identified, sometimes in combination with dietary change. In bacterial-aetiology cases, targeted antibiotic treatment has been used. Probiotic supplementation to support microbiome rebalancing has been included in some reported treatment protocols, though the evidence for specific probiotic strains in ABS is not yet established.
Relapses following treatment are described in some cases, particularly with resumed high-carbohydrate dietary patterns, underscoring the importance of sustained dietary management alongside any pharmacological intervention.
A Note on Self-Directed Approaches
Because ABS sits within the domain of gut microbiome health, it appears in discussions of functional medicine and holistic health approaches. The dietary and microbiome-focused aspects of its management do align with integrative medicine frameworks, and some practitioners in this space have experience with the condition.
However, the framing of ABS as an explanation to explore independently — without formal clinical investigation — carries real risk. The symptoms that might prompt suspicion of ABS can reflect serious conditions that require prompt medical attention. Anyone experiencing unexplained intoxication-like episodes, significant cognitive impairment, or other concerning symptoms should seek a GP referral and formal specialist evaluation rather than pursuing self-directed treatment.
